J0739 Insurance Policy Changes

HCPCS J0739 is officially defined as "Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)." HCPCS J0739 is referenced in 5 tracked payer policy changes from Harvard Pilgrim Health Care, Arkansas Blue Cross Blue Shield, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0739 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.